Emily Luxford1, Karen I Berliner, Jacqueline Lee, William M Luxford. 1. *VA Medical Center, Los Angeles; †House Research Institute, Marina del Rey; ‡Nutrition and Dietetics, California State University, Long Beach; and §House Clinic and House Research Institute, Los Angeles, California, U.S.A.
Abstract
OBJECTIVE: To evaluate ease of use and compliance with dietary modification in the treatment of vertigo in patients with Ménière's disease. STUDY DESIGN: Mailed patient retrospective questionnaire and chart review. SETTING: Tertiary referral neurotologic private practice. SUBJECTS: 136 patients with Ménière's who returned a mailed questionnaire. Mean age at first clinic visit was 53 years, and at questionnaire was 62 years, with 54.4% female subjects. Median initial hearing was AAO-HNS Stage 1. Most patients also received diuretics and/or other treatments. INTERVENTION: Reduced sodium and caffeine-free diet. MAIN OUTCOME MEASURES: Ratings of diet difficulty, length of use, compliance level and nutritional understanding, and AAO-HNS vertigo class and functional rating before and with nutritional intervention. RESULTS: 46.3% of the respondents received written diet guidelines; only 3.2% were referred for nutritional counseling, and another 7.8% sought counseling independently. 77.8% and 84.7% rated a low sodium and a caffeine-free diet, respectively, as manageable or easy to follow; 77.9% followed the diet for 1 year or greater, but only 10.3% could list 5 "correct" foods to eat and 26% 5 foods to avoid. Those who followed the diet greater than 6 months had larger improvement in number of spells and functional rating and a higher rate of Class A/B vertigo outcome (p ≤ 0.01, p = 0.012, and p = 0.038, respectively). Knowledge of foods to eat and avoid correlated with vertigo class (rho = -0.21, p ≤ 0.029 and rho = -0.26, p ≤ 0.01, respectively); the more foods correctly listed, the better the AAO-HNS class). CONCLUSION: Nutrition education by referral to a registered dietitian may improve outcomes in the medical treatment of Ménière's disease.
OBJECTIVE: To evaluate ease of use and compliance with dietary modification in the treatment of vertigo in patients with Ménière's disease. STUDY DESIGN: Mailed patient retrospective questionnaire and chart review. SETTING: Tertiary referral neurotologic private practice. SUBJECTS: 136 patients with Ménière's who returned a mailed questionnaire. Mean age at first clinic visit was 53 years, and at questionnaire was 62 years, with 54.4% female subjects. Median initial hearing was AAO-HNS Stage 1. Most patients also received diuretics and/or other treatments. INTERVENTION: Reduced sodium and caffeine-free diet. MAIN OUTCOME MEASURES: Ratings of diet difficulty, length of use, compliance level and nutritional understanding, and AAO-HNS vertigo class and functional rating before and with nutritional intervention. RESULTS: 46.3% of the respondents received written diet guidelines; only 3.2% were referred for nutritional counseling, and another 7.8% sought counseling independently. 77.8% and 84.7% rated a low sodium and a caffeine-free diet, respectively, as manageable or easy to follow; 77.9% followed the diet for 1 year or greater, but only 10.3% could list 5 "correct" foods to eat and 26% 5 foods to avoid. Those who followed the diet greater than 6 months had larger improvement in number of spells and functional rating and a higher rate of Class A/B vertigo outcome (p ≤ 0.01, p = 0.012, and p = 0.038, respectively). Knowledge of foods to eat and avoid correlated with vertigo class (rho = -0.21, p ≤ 0.029 and rho = -0.26, p ≤ 0.01, respectively); the more foods correctly listed, the better the AAO-HNS class). CONCLUSION: Nutrition education by referral to a registered dietitian may improve outcomes in the medical treatment of Ménière's disease.
Authors: Norm R C Campbell; Paul K Whelton; Marcelo Orias; Richard D Wainford; Francesco P Cappuccio; Nicole Ide; Bruce Neal; Jennifer Cohn; Laura K Cobb; Jacqui Webster; Kathy Trieu; Feng J He; Rachael M McLean; Adriana Blanco-Metzler; Mark Woodward; Nadia Khan; Yoshihiro Kokubo; Leo Nederveen; JoAnne Arcand; Graham A MacGregor; Mayowa O Owolabi; Liu Lisheng; Gianfranco Parati; Daniel T Lackland; Fadi J Charchar; Bryan Williams; Maciej Tomaszewski; Cesar A Romero; Beatriz Champagne; Mary R L'Abbe; Michael A Weber; Markus P Schlaich; Agnes Fogo; Valery L Feigin; Rufus Akinyemi; Felipe Inserra; Bindu Menon; Marcia Simas; Mario Fritsch Neves; Krassimira Hristova; Carolyn Pullen; Sanjay Pandeya; Junbo Ge; Jorge E Jalil; Ji-Guang Wang; Jiri Wideimsky; Reinhold Kreutz; Ulrich Wenzel; Michael Stowasser; Manuel Arango; Athanasios Protogerou; Eugenia Gkaliagkousi; Flávio Danni Fuchs; Mansi Patil; Andy Wai-Kwong Chan; János Nemcsik; Ross T Tsuyuki; Sanjeevi Nathamuni Narasingan; Nizal Sarrafzadegan; María Eugenia Ramos; Natalie Yeo; Hiromi Rakugi; Agustin J Ramirez; Guillermo Álvarez; Adel Berbari; Cho-Il Kim; Sang-Hyun Ihm; Yook-Chin Chia; Tsolmon Unurjargal; Hye Kyung Park; Kolawole Wahab; Helen McGuire; Naranjargal J Dashdorj; Mohammed Ishaq; Deborah Ignacia D Ona; Leilani B Mercado-Asis; Aleksander Prejbisz; Marianne Leenaerts; Carla Simão; Fernando Pinto; Bader Ali Almustafa; Jonas Spaak; Stefan Farsky; Dragan Lovic; Xin-Hua Zhang Journal: J Hum Hypertens Date: 2022-05-17 Impact factor: 2.877